- Posted by Bianca Johnston
- On July 29, 2019
- 0 Comments
Colair is proud to have been involved in a project at GSK’s (GlaxoSmithKline) production plant at the foothills of Melbourne’s Dandenon Ranges, where our AHUs & FCUs were used to complete the project.
Following is an extract from AIRAH’s May 2017 edition of Ecolibrium, which featured this exciting project. You can access the full article by clicking the link below.
Accurate and consistent climate control is paramount in all pharmaceutical environments. This is especially so in a blow-fill-seal manufacturing facility such as that found in Melbourne’s outer east.
The GSK (GlaxoSmithKline Australia) production plant in Boronia produces a range of respiratory products, including Ventolin, Flixotide and Relenza, which are used in the treatment of asthma, influenza and other respiratory infections. These products are delivered in various forms, including the well-known Ventolin puffers and nebules.
GSK’s nebule products are manufactured using a state-of-the-art blow-fill-seal (BFS) manufacturing technique at the Boronia facility. The BFS area of the facility was built in 2000. Here, a container is formed from a polymer, which is then filled and sealed in a continuous process in a sterile, enclosed area inside a machine – without human intervention. This technique can be used to aseptically manufacture sterile pharmaceutical liquid dosage forms. It is considered to be the superior form of aseptic (sterilised, basically) filling. In order to support this process, a Good Manufacturing Practice (GMP) Grade C Clean Room environment needs to be achieved and maintained by the facility’s HVAC systems.